论文部分内容阅读
目的研究支气管哮喘患者吸入糖皮质激素治疗依从性与病情控制之间的关系,并查找吸入糖皮质激素治疗依从性的主要影响因素。方法 200例支气管哮喘患者,对其进行吸入糖皮质激素依从性量表调查、哮喘控制测试(ACT)以及吸入糖皮质激素影响因素问卷调查,统计并分析相关调查结果。结果 200例患者中有59.5%吸入糖皮质激素依从性佳,40.5%的患者不能很好地依从医嘱吸入糖皮质激素;5.0%患者支气管哮喘病情为完全控制,43.0%患者病情为部分控制,52.0%患者哮喘病情为未控制;将患者吸入糖皮质激素依从性与病情控制率进行比较,支气管哮喘病情控制率随吸入糖皮质激素依从性的提高而增加,呈正相关;影响患者吸入糖皮质激素的主要因素有哮喘防治知识缺乏、恐惧激素类药物、治疗周期过长,无法长期坚持使用、使用方法及剂量繁琐以及药费昂贵,无法承担5大类。结论提高支气管哮喘患者吸入糖皮质激素治疗依从性可以从主要影响因素入手,可有效提高哮喘控制水平。
Objective To study the relationship between the compliance of inhaled glucocorticoid therapy and disease control in patients with bronchial asthma and to find out the main influencing factors of compliance with inhaled glucocorticoid therapy. Methods A total of 200 patients with bronchial asthma were surveyed by questionnaire about inhaled glucocorticoid compliance scale, asthma control test (ACT) and inhaled glucocorticoid influential factors, and statistics and analysis of relevant findings were made. Results 59.5% of 200 patients had good glucocorticosteroid compliance, 40.5% of patients did not comply with the orders of inhalation glucocorticosteroids, 5.0% of patients had complete control of bronchial asthma, 43.0% of patients were partially controlled, 52.0 % Of patients with asthma uncontrolled; patients with glucocorticoid compliance and disease control rates were compared, bronchial asthma control rate with the inhalation of glucocorticoid compliance increased, positively correlated; affecting patients with inhaled corticosteroids The main factors are the lack of knowledge of prevention and treatment of asthma, hormonal hormonal drugs, the treatment cycle is too long, can not adhere to long-term use, use and dosage cumbersome and expensive drugs, can not afford 5 categories. Conclusions Increasing compliance of glucocorticoid treatment in patients with bronchial asthma can start with the main influencing factors and can effectively improve the control level of asthma.